Literature DB >> 11929808

Hormonal regulation of VEGF in orthotopic MCF7 human breast cancer.

Liora Bogin1, Hadassa Degani.   

Abstract

Vascular endothelial growth factor (VEGF) mRNA and protein levels were higher in MCF7 breast cancer cells and orthotopic tumors after treatment with tamoxifen, as compared with treatment with estrogen. Accordingly, tumor vascular permeability, evaluated in vivo from contrast-enhanced magnetic resonance imaging, was elevated during treatment with tamoxifen. The results indicate that estrogen regulates angiogenesis in MCF7 tumors by maintaining VEGF at levels sufficient for the generation of functional microcapillaries and consequently facilitates tumor growth. During tamoxifen treatment, estrogen regulation is removed, and VEGF increases to levels that enhance markedly vascular permeability and reduce their perfusion function, leading to inhibition of tumor progression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11929808

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  24 in total

1.  The role of steroid hormones on the regulation of vascular endothelial growth factor.

Authors:  Salman M Hyder
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

Review 2.  The mammary gland vasculature revisited.

Authors:  Anne-Catherine Andres; Valentin Djonov
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-08-14       Impact factor: 2.673

3.  Water exchange-minimizing DCE-MRI protocol to detect changes in tumor vascular parameters: effect of bevacizumab/paclitaxel combination therapy.

Authors:  Wenlian Zhu; Yoshinori Kato; Dmitri Artemov
Journal:  MAGMA       Date:  2013-06-27       Impact factor: 2.310

4.  Molecular expression of vascular endothelial growth factor, prokineticin receptor-1 and other biomarkers in infiltrating canalicular carcinoma of the breast.

Authors:  Angélica Morales; Sumiko Morimoto; Felipe Vilchis; Natsuko Taniyama; Claudia J Bautista; Carlos Robles; Enrique Bargalló
Journal:  Oncol Lett       Date:  2016-08-05       Impact factor: 2.967

5.  Effect of tamoxifen on serum IL-18, vascular endothelial growth factor and nitric oxide activities in breast carcinoma patients.

Authors:  U Coskun; N Gunel; B Sancak; E Onuk; M Bayram; A Cihan
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

6.  Vascular endothelial growth factor and breast cancer risk.

Authors:  Katherine W Reeves; Roberta B Ness; Roslyn A Stone; Joel L Weissfeld; Victor G Vogel; Robert W Powers; Francesmary Modugno; Jane A Cauley
Journal:  Cancer Causes Control       Date:  2008-11-06       Impact factor: 2.506

7.  HEXIM1 modulates vascular endothelial growth factor expression and function in breast epithelial cells and mammary gland.

Authors:  N Ogba; Y Q Doughman; L J Chaplin; Y Hu; M Gargesha; M Watanabe; M M Montano
Journal:  Oncogene       Date:  2010-05-10       Impact factor: 9.867

8.  Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling.

Authors:  Yong-Yu Liu; Vineet Gupta; Gauri A Patwardhan; Kaustubh Bhinge; Yunfeng Zhao; Jianxiong Bao; Harihara Mehendale; Myles C Cabot; Yu-Teh Li; S Michal Jazwinski
Journal:  Mol Cancer       Date:  2010-06-11       Impact factor: 27.401

9.  Single-step nanoplasmonic VEGF165 aptasensor for early cancer diagnosis.

Authors:  Hansang Cho; Erh-Chia Yeh; Raghu Sinha; Ted A Laurence; Jane P Bearinger; Luke P Lee
Journal:  ACS Nano       Date:  2012-08-21       Impact factor: 15.881

10.  A new mixed-backbone oligonucleotide against glucosylceramide synthase sensitizes multidrug-resistant tumors to apoptosis.

Authors:  Gauri A Patwardhan; Qian-Jin Zhang; Dongmei Yin; Vineet Gupta; Jianxiong Bao; Can E Senkal; Besim Ogretmen; Myles C Cabot; Girish V Shah; Paul W Sylvester; S Michal Jazwinski; Yong-Yu Liu
Journal:  PLoS One       Date:  2009-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.